About Indiabulls Pharmaceuticals
Indiabulls Pharmaceuticals is a Healthcare company based in Mumbai (India) founded in 2016 by Nikhil Chari. Manufacturer of generic products and medical devices for both chronic and acute therapies. Indiabulls Pharmaceuticals has raised $47.57 million across 2 funding rounds from investors including The Clermont and Indiabestbuy. The company has 340 employees. Indiabulls Pharmaceuticals was last valued at $275.66 million in November 2017. Its chief executive, as recorded, is Nikhil Chari. Its Indian entity Indiabulls Pharmaceuticals Limited reported revenue of ₹75.33 Cr. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.
Company details
Indiabulls Pharmaceuticals was established in 2016 in Mumbai, India, within the pharmaceuticals sector. Generic formulations and medical devices are produced for therapies addressing chronic and acute conditions. Operations rely on a network of GMP-certified manufacturing facilities for sourcing. The portfolio encompasses categories such as respiratory care, cardiometabolic and cardiovascular wellness, womens health care, and additional areas.
- Headquarters Mumbai, India
- Employees 340
- Founders Nikhil Chari
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website indiabullspharmaceuticals.com
- Social X
- Legal Name Indiabulls Pharmaceuticals Limited
- Date of Incorporation 06 Jul, 2016
- Jurisdiction Haryana, India
- Annual Revenue₹75.33 Cr
FY 2022 · +42% YoY
- Net Loss-₹75.19 Cr
FY 2022 · -100% margin
- EBITDA-₹52.94 Cr
FY 2022 · -70% margin
- Total Equity Funding$47.57M (USD)
in 2 rounds
- Latest Funding Round$24.02M (USD), Series A
Nov 2017
- InvestorsThe Clermont
& 1 more
- Employee Count340
Associated legal entities of Indiabulls Pharmaceuticals
Indiabulls Pharmaceuticals operates through Indiabulls Pharmaceuticals Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Indiabulls Pharmaceuticals Limited CIN U33119HR2016PLC078088 | Active | 06 Jul 2016 | ₹75.3 Cr | 340 | 3 | View details |
Funding Insights of Indiabulls Pharmaceuticals
Indiabulls Pharmaceuticals has successfully raised a total of $47.57M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $24.02 million completed in November 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $47.57M
- Total Rounds 2
- Last Round Series A — $24.02M
- First Round $23.55M
(Nov 2016)
- Investors Count 2
All 2 funding rounds of Indiabulls Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2017 | $24.02M | Series A | $275.66M | The Clermont | – |
| Nov 2016 | $23.55M | Series A | $240.72M | The Clermont, Indiabestbuy | – |
| Date | Valuation | Stage |
|---|---|---|
| Nov 2017 | $275.66M | •••••••• |
| Nov 2016 | $240.72M | •••••••• |
Last known valuation $275.66M (Nov 2017). 2 investors in total: 2 institutional.
Investors in Indiabulls Pharmaceuticals
Indiabulls Pharmaceuticals has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include The Clermont and Indiabestbuy.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are directed toward Singapore by The Clermont. | clermont.com | Singapore, Singapore | ||
| indiabestbuy.tcc.mode |
Investor details for Indiabulls Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Indiabulls Pharmaceuticals Limited (Indiabulls Pharmaceuticals)
Indiabulls Pharmaceuticals Limited is the primary company behind Indiabulls Pharmaceuticals. The board of Indiabulls Pharmaceuticals Limited currently have 3 directors; the longest-serving is Vidya Nand, appointed in 2020. 12 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vidya Nand DIN 08267224 | Director | 20 Aug 2020 | 6 yrs 2 mo | Indiabulls Pharmaceuticals Limited |
| Anand Kumar DIN 08267718 | Director | 20 Aug 2020 | 6 yrs 2 mo | Indiabulls Pharmaceuticals Limited |
| Monika Panghal DIN 09594183 | Director | 22 Aug 2022 | 4 yrs 2 mo | Indiabulls Pharmaceuticals Limited |
People of Indiabulls Pharmaceuticals
1 people are tracked at Indiabulls Pharmaceuticals (1 in leadership); the tracked headcount is 340.
| Name | Role | Group |
|---|---|---|
Nikhil Chari | Co-Founder & CEO | Leadership |
Complete people profiles for Indiabulls Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Indiabulls Pharmaceuticals
Figures of Indiabulls Pharmaceuticals Limited, the primary company behind Indiabulls Pharmaceuticals, for FY 2022. Revenue was ₹75.33 Cr (+42% year on year). Net loss was -₹75.19 Cr (-100% margin). EBITDA was -₹52.94 Cr (-70% margin). Revenue has grown at a compounded annual rate of +32% over three years and +196% over five years.
- ₹75.33 CrRevenue · FY 2022 · +42% YoY
- -₹75.19 CrNet loss · -100% margin
- -₹52.94 CrEBITDA · -70% margin
- ₹6.28 CrPaid-up capital
- 340Employees (provident fund records)
- +32%Revenue CAGR, 3 years
- +196%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Indiabulls Pharmaceuticals Limited are on its company page.
Detailed financial statements for Indiabulls Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Indiabulls Pharmaceuticals
4 dated milestones of Indiabulls Pharmaceuticals across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Indiabulls Pharmaceuticals is founded.
- Funding First funding round of $23.6M.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Series A, of $24.0M.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Indiabulls Pharmaceuticals (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | USD 508.93 M | 5,180 | ||
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | USD 6.21 B | 25,870 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Indiabulls Pharmaceuticals
Complete news archive for Indiabulls Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Indiabulls Pharmaceuticals
Indiabulls Pharmaceuticals was founded in 2016.
Indiabulls Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Nikhil Chari is the CEO of Indiabulls Pharmaceuticals, as recorded in our data. They have also founded this company.
Indiabulls Pharmaceuticals is a funded company, having raised a total of $47.57M across 2 funding rounds to date. The company's 1st funding round was a Series A of $23.55M, raised on Nov 2016.
Indiabulls Pharmaceuticals has 340 employees.
The primary company behind Indiabulls Pharmaceuticals, Indiabulls Pharmaceuticals Limited, reported revenue of ₹75.33 Cr for FY 2022, up 42% year on year.
Indiabulls Pharmaceuticals was established in 2016 in Mumbai, India, within the pharmaceuticals sector. Generic formulations and medical devices are produced for therapies addressing chronic and acute conditions. Operations rely on a network of GMP-certified manufacturing facilities for sourcing. The portfolio encompasses categories such as respiratory care, cardiometabolic and cardiovascular wellness, womens health care, and additional areas.
Indiabulls Pharmaceuticals has 2 investors. Key investors include The Clermont, and Indiabestbuy.
The valuation of Indiabulls Pharmaceuticals is $275.66M as of Nov 2017.
Indiabulls Pharmaceuticals operates through Indiabulls Pharmaceuticals Limited.
The legal entities of Indiabulls Pharmaceuticals currently have 3 directors, including Vidya Nand, Monika Panghal, Anand Kumar.